Context and number of noncanonical repeat variable diresidues impede the design of TALE proteins with improved DNA targeting

Protein Sci. 2020 Feb;29(2):606-616. doi: 10.1002/pro.3801. Epub 2019 Dec 24.

Abstract

Transcription activator-like effector (TALE) proteins have been used extensively for targeted binding of fusion proteins to loci of interest in (epi)genome engineering. Such approaches typically utilize four canonical TALE repeat variable diresidue (RVD) types, corresponding to the identities of two key amino acids, to target each nucleotide. Alternate RVDs with improved specificity are desired. Here, we focused on seven noncanonical RVDs that have been suggested to have improved specificity for their target nucleotides. We used custom protein binding microarrays to characterize the DNA-binding activity of 65 TALEs containing these alternate or corresponding canonical RVDs at multiple positions to ~5,000 unique DNA sequences per protein. We found that none of the noncanonical thymine-targeting RVDs displayed stronger preference for thymine than did the canonical RVD. Of the noncanonical RVDs with putatively improved specificity for guanine, only EN and NH showed greater discrimination of guanine over adenine. This improved specificity, however, comes at a cost: more substitutions of a noncanonical RVD for a canonical RVD generally decreased the protein's DNA-binding activity. Our results highlight the need to investigate RVD-nucleotide specificities in multiple protein contexts and suggest that a balance between canonical and noncanonical RVDs is needed to build TALEs with improved specificity.

Keywords: RVDs; TALEs; genome engineering; nucleotide specificity; protein binding microarray.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • DNA / chemistry
  • DNA / genetics*
  • Genetic Variation / genetics
  • Protein Array Analysis
  • Repetitive Sequences, Amino Acid
  • Transcription Activator-Like Effectors / chemistry
  • Transcription Activator-Like Effectors / genetics*

Substances

  • Transcription Activator-Like Effectors
  • DNA